Assignee
AGENSYS INC
US·165 granted patents·32 pending applications·1,549 citations·filing 1999–2025
Top patents by PatentIndex Score
197 records- 0199US7485299B2Serpentine transmembrane antigens expressed in human cancers and uses thereofAGENSYS INC·Filed 2006·Granted Feb 3, 2009·49 cites·18 claims
- 0298US11739155B2Antibodies that bind to AXL proteinsAGENSYS INC·Filed 2020·Granted Aug 29, 2023·4 cites·18 claims
- 0398US11718677B2Antibodies that bind to AXL proteinsAGENSYS INC·Filed 2020·Granted Aug 8, 2023·4 cites·18 claims
- 0498US7507541B236P6D5: secreted tumor antigenAGENSYS INC·Filed 2007·Granted Mar 24, 2009·89 cites·26 claims
- 0598US6329503B1Serpentine transmembrane antigens expressed in human cancers and uses thereofAGENSYS INC·Filed 1999·Granted Dec 11, 2001·147 cites·16 claims
- 0697US11559582B2Antibody drug conjugates (ADC) that bind to 191P4D12 proteinsAGENSYS INC·Filed 2020·Granted Jan 24, 2023·3 cites·32 claims
- 0797US8013128B2Antibodies and related molecules that bind to PSCA proteinsAGENSYS INC·Filed 2009·Granted Sep 6, 2011·28 cites·22 claims
- 0897US7968090B2Nucleic acids and corresponding proteins entitled 191P4D12(b) useful in treatment and detection of cancerAGENSYS INC·Filed 2010·Granted Jun 28, 2011·19 cites·18 claims
- 0997US7641905B2Methods of inducing an immune responseAGENSYS INC·Filed 2005·Granted Jan 5, 2010·25 cites·4 claims
- 1097US7628989B2Methods of inducing an immune responseAGENSYS INC·Filed 2005·Granted Dec 8, 2009·23 cites·4 claims
- 1197US7541442B2Antibodies and related molecules that bind to PSCA proteinsAGENSYS INC·Filed 2006·Granted Jun 2, 2009·26 cites·19 claims
- 1296US10787516B2Antibodies that bind to AXL proteinsAGENSYS INC·Filed 2016·Granted Sep 29, 2020·8 cites·18 claims
- 1396US10787517B2Antibodies that bind to AXL proteinsAGENSYS INC·Filed 2016·Granted Sep 29, 2020·8 cites·18 claims
- 1496US7947276B2Antibodies and molecules derived therefrom that bind to STEAP-1 proteinsAGENSYS INC·Filed 2006·Granted May 24, 2011·18 cites·9 claims
- 1596US7595379B2Antibodies and related molecules that bind to PSCA proteinsAGENSYS INC·Filed 2005·Granted Sep 29, 2009·34 cites·7 claims
- 1696US7361338B2Methods to inhibit growth of prostate cancer cellsAGENSYS INC·Filed 2002·Granted Apr 22, 2008·40 cites·12 claims
- 1796US7053186B2Antibodies immunospecific for STEAP1AGENSYS INC·Filed 2001·Granted May 30, 2006·48 cites·7 claims
- 1895USRE47103EAntibody drug conjugates (ADC) that bind to 158P1D7 proteinsAGENSYS INC·Filed 2017·Granted Oct 30, 2018·7 cites·67 claims
- 1995US8013135B2Antibodies and molecules derived therefrom that bind to STEAP-1 proteinsAGENSYS INC·Filed 2006·Granted Sep 6, 2011·16 cites·4 claims
- 2095US7494646B2Antibodies and molecules derived therefrom that bind to STEAP-1 proteinsAGENSYS INC·Filed 2004·Granted Feb 24, 2009·38 cites·21 claims
- 2195US7427399B2Antibodies and related molecules that bind to 161P2F10B proteinsAGENSYS INC·Filed 2006·Granted Sep 23, 2008·21 cites·21 claims
- 2294US7928201B2Serpentine transmembrane antigens expressed in human cancers and uses thereofAGENSYS INC·Filed 2009·Granted Apr 19, 2011·16 cites·20 claims
- 2394US7749746B2Nucleic acid encoding 238P1B2 useful in detecting cancerAGENSYS INC·Filed 2009·Granted Jul 6, 2010·9 cites·11 claims
- 2494US7642054B2Serpentine transmembrane antigens expressed in human cancers and uses thereofAGENSYS INC·Filed 2005·Granted Jan 5, 2010·19 cites·21 claims
- 2594US7611904B2Serpentine transmembrane antigens expressed in human cancers and uses thereofAGENSYS INC·Filed 2006·Granted Nov 3, 2009·19 cites·39 claims
- 2694US7166714B2Serpentine transmembrane antigens expressed in human cancers and uses thereofAGENSYS INC·Filed 2003·Granted Jan 23, 2007·35 cites·6 claims
- 2794US7067130B2Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancerAGENSYS INC·Filed 2002·Granted Jun 27, 2006·27 cites·12 claims
- 2894US6887975B2Peptides derived from STEAP1AGENSYS INC·Filed 2001·Granted May 3, 2005·40 cites·8 claims
- 2993US10894090B2Antibody drug conjugates (ADC) that bind to 191P4D12 proteinsAGENSYS INC·Filed 2018·Granted Jan 19, 2021·4 cites·38 claims
- 3093US9314538B2Nucleic acid molecules encoding antibody drug conjugates (ADC) that bind to 191P4D12 proteinsAGENSYS INC·Filed 2015·Granted Apr 19, 2016·9 cites·33 claims
- 3193US8968742B2Antibody drug conjugates (ADC) that bind to 158P1D7 proteinsAGENSYS INC·Filed 2013·Granted Mar 3, 2015·7 cites·32 claims
- 3293US7968307B2Serpentine transmembrane antigens expressed in human cancers and uses thereofAGENSYS INC·Filed 2009·Granted Jun 28, 2011·14 cites·22 claims
- 3393US7884179B2Nucleic acid and corresponding protein entitled STEAP-1 useful in treatment and detection of cancerAGENSYS INC·Filed 2006·Granted Feb 8, 2011·20 cites·5 claims
- 3493US7811565B2Antibodies and related molecules that bind to 161P2F10B proteinsAGENSYS INC·Filed 2009·Granted Oct 12, 2010·20 cites·20 claims
- 3592US9078931B2Antibody drug conjugates (ADC) that bind to 191P4D12 proteinsAGENSYS INC·Filed 2013·Granted Jul 14, 2015·11 cites·8 claims
- 3692US7667018B2Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancerAGENSYS INC·Filed 2007·Granted Feb 23, 2010·10 cites·8 claims
- 3792US7592149B2Nucleic acid and corresponding protein entitled 184P1E2 useful in treatment and detection of cancerAGENSYS INC·Filed 2006·Granted Sep 22, 2009·5 cites·10 claims
- 3892US7226594B2Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancerAGENSYS INC·Filed 2002·Granted Jun 5, 2007·25 cites·13 claims
- 3992US6943235B1Transmembrane protein expressed in prostate cancerAGENSYS INC·Filed 2000·Granted Sep 13, 2005·34 cites·10 claims
- 4091US9962454B2Antibody drug conjugates (ADC) that bind to 191P4D12 proteinsAGENSYS INC·Filed 2016·Granted May 8, 2018·6 cites·5 claims
- 4191US9926376B2Antibody drug conjugates (ADC) that bind to 158P1D7 proteinsAGENSYS INC·Filed 2016·Granted Mar 27, 2018·4 cites·24 claims
- 4291US8039597B2Antibodies and related molecules that bind to 24P4C12 proteinsAGENSYS INC·Filed 2008·Granted Oct 18, 2011·11 cites·24 claims
- 4391US7939503B2Reduction of cell-cell communication in prostate cancer using STEAP-1 siRNAAGENSYS INC·Filed 2004·Granted May 10, 2011·17 cites·1 claims
- 4491US7553814B2238P1B2 proteinAGENSYS INC·Filed 2006·Granted Jun 30, 2009·5 cites·3 claims
- 4591US7405290B2Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancerAGENSYS INC·Filed 2004·Granted Jul 29, 2008·23 cites·14 claims
- 4691US7037667B1Tumor antigen useful in diagnosis and therapy of prostate and colon cancerAGENSYS INC·Filed 2000·Granted May 2, 2006·41 cites·10 claims
- 4791US6893818B1Gene upregulated in cancers of the prostateAGENSYS INC·Filed 2000·Granted May 17, 2005·19 cites·1 claims
- 4890US10669348B2Antibody drug conjugates (ADC) that bind to 158P1D7 proteinsAGENSYS INC·Filed 2018·Granted Jun 2, 2020·2 cites·30 claims
- 4990US9617346B2Antibodies and molecules derived therefrom that bind to STEAP-1 proteinsAGENSYS INC·Filed 2015·Granted Apr 11, 2017·6 cites·16 claims
- 5090US8012937B2Nucleic acid and corresponding protein entitled 98P4B6 useful in treatment and detection of cancerAGENSYS INC·Filed 2006·Granted Sep 6, 2011·9 cites·5 claims
Showing the top 50 of 197 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →